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Endocannabinoids are important players in neural development and function. They act
via receptors, whose activation inhibits cAMP production. The aim of the paper was to
look for calcium- and cAMP-signaling cross-talk mediated by cannabinoid CB1 receptors
(CB1R) and to assess the relevance of EF-hand CaM-like calcium sensors in this regard.
Using a heterologous expression system, we demonstrated that CB1R interacts with
calneuron-1 and NCS1 but not with caldendrin. Furthermore, interaction motives were
identified in both calcium binding proteins and the receptor, and we showed that the
first two sensors competed for binding to the receptor in a Ca2+-dependent manner.
Assays in neuronal primary cultures showed that, CB1R-NCS1 complexes predominate
at basal Ca2+ levels, whereas in the presence of ionomycin, a calcium ionophore,
CB1R-calneuron-1 complexes weremore abundant. Signaling assays following forskolin-
induced intracellular cAMP levels showed in mouse striatal neurons that binding of
CB1R to NCS1 is required for CB1R-mediated signaling, while the binding of CB1R
to calneuron-1 completely blocked Gi-mediated signaling in response to a selective
receptor agonist, arachidonyl-2-chloroethylamide. Calcium levels and interaction with
calcium sensors may even lead to apparent Gs coupling after CB1R agonist challenge.
Keywords: caldendrin, calneuron-1, calmodulin, CB1 and CB2 cannabinoid receptors, development,
endocannabinoids, G-protein-coupled receptor, frequenin/NCS1
INTRODUCTION
The mechanisms involved in the cross-talk at the level of the two main second messengers, Ca2+
and cAMP, are not fully elucidated despite being seminal for neuronal function. Regulation of
intracellular Ca2+ concentration is key for neural development and for brain function and plasticity
(Connor et al., 1986; Landfield et al., 1986; Kotlyar and Pivovarov, 1990; Mattson, 1990; Pontzer
et al., 1990). Intracellular calcium ion is a second messenger that interacts and affects the structure
of a variety of proteins. Although the more studied has been calmodulin (CaM), other calcium
binding proteins have been identified and partially characterized (Mikhaylova et al., 2011). Upon
ion binding, these calcium-binding proteins are able to participate in a myriad of relevant cellular
events, inter alia proliferation, differentiation and apoptosis (Hyman and Pfenninger, 1985; Stichel
et al., 1987; Forscher, 1989; Joseph et al., 1993; Orrenius and Nicotera, 1994; Orrenius et al., 2003).
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Calneuron-1, caldendrin and frequenin are among the
calcium-binding proteins abundantly expressed in the central
nervous system (CNS). Frequenin, which was identified by
its role in the development of the nervous system and the
morphology of neurons in snails and fruit flies (see Dason
et al., 2012 for review), is also known as neuronal calcium
sensor 1 (NCS1). All these proteins share EF-hand domains and
regulation of complex neuronal responses that are dependent
on calcium gradients. Calneuron-1 presents 4 EF-hand domains,
of which only 2 are functional and able to bind calcium with
high affinity. Calneuron-1 is a transmembrane protein that
binds calcium with considerably higher affinity than NCS1
(Mikhaylova et al., 2006, 2009; McCue et al., 2010; Hradsky et al.,
2011; Burgoyne and Haynes, 2012).
Endocannabinoids and Cannabis sativa-derived
phytocannabinoids act via two G-protein-coupled receptors
(GPCRs), CB1 and CB2 (Matsuda et al., 1990; Griffin et al., 2000;
Brown et al., 2002). GPCRs couple to heterotrimeric G proteins,
mainly to Gs, which activates the enzyme that produces the
second messenger cAMP, to Gi, which inhibits the enzyme, or
to Gq that leads to increases in the level of intracellular calcium
ion (Millar and Newton, 2010; Hausch and Holsboer, 2012).
CB1 is the GPCR with highest expression in CNS neurons and
couples to Gi proteins. GPCR function may be regulated by
interacting proteins (Ritter and Hall, 2009) such as EF-hand
CaM like calcium sensors, which may affect the traffick and
function of neurotransmitters/neuromodulator GPCRs (Kabbani
et al., 2002; Seidenbecher et al., 2004; Mikhaylova et al., 2009;
Lian et al., 2011; Navarro et al., 2012, 2014). The aim of this
paper was to look for interactions between calcium sensors
and the cannabinoid CB1 receptor. The results show that
endocannabinoid action in neurons is regulated by cAMP-Ca2+




Ionomycin calcium salt from Streptomyces conglobatus
was purchased from SigmaAldrich (St Louis, MO), and
Arachidonyl-2
′
-chloroethylamide (ACEA) and rimonabant from
Tocris Bioscience (Bristol, UK).
Expression Vectors
Plasmids containing the human version of all proteins, coding
for either full-length or point or deletion mutants were used.
In the case of the human CB1R (obtained from cDNA
resource center), two mutants were used. One of them (CB1IL3)
had mutations in the residues susceptible of phosphorylation
located in the third intracellular loop (from 321TSEDGKVQV329
to 321AAEDGKVQV329); they were prepared as described
elsewhere by site-directed mutagenesis (Cellogenetics, Ijamsville,
MD, USA; see Navarro et al., 2010). PCR was used to remove
the last 40 amino acids of the CB1R (CB
1C
1 ). cDNA for
the human version of cannabinoid CB1R (mutated or not)
without its stop codon, were subcloned to RLuc-containing
vector (pRLuc-N1; PerkinElmer, Wellesley, MA) using sense and
antisense primers harboring unique restriction sites for HindIII
and BamHI or subcloned to pEYFP-containing vector (pEYFP-
N1; Clontech, Heidelberg, Germany) using sense and antisense
primers harboring unique restriction sites for BamHI and
KpnI generating CB1R-RLuc and CB1R-YFP. cDNA constructs
encoding NCS1 or caldendrin in pcDNA3 vectors, kindly
provided by Prof. Michael R. Kreutz were subcloned in pEYFP-
N1 vector as previously described (Navarro et al., 2012)
to generate NCS1-YFP and caldendrin-YFP, fusion proteins.
Calneuron-1 sequence, cloned into pcDNA3.1 (provided by Prof.
Kreutz), was amplified without its stop codon using sense and
antisense primers harboring unique BamHI and HindIII sites
to subclone calneuron-1 in pRLuc-N1vector or HindIII and
BamHI to subclone calneuron-1 in pEYFP-N1 vector, giving the
plasmids that express calneuron-1-RLuc and calneuron-1-YFP.
Calneuron-1 construct truncated in the C terminus (calneuron-
11C) and N-terminal myristoylation-deficient NCS1 mutant
(NCS11myristoil) in which YFP is fused to the N terminus of
NCS1 obtained as described elsewhere (Hradsky et al., 2013)
were kindly provided by Michael R. Kreutz. Fusion proteins
corresponding to mutant sensors were obtained following the
above described methodology.
Cell Culture and Transient Transfection
HEK-293T cells were grown in DMEM medium (Gibco, Paisley,
Scotland, UK) supplemented with 2mM L-glutamine, 100
U/ml penicillin/streptomycin, MEM non-essential amino acids
solution (1/100) and 5% (v/v) heat inactivated fetal bovine serum
(FBS) (Invitrogen, Paisley, Scotland, UK). Cells were maintained
in a humid atmosphere of 5% CO2 at 37
◦C. Cells were transiently
transfected with the PEI (PolyEthylenImine, Sigma, St. Louis,
MO, USA) method as previously described (Navarro et al., 2015).
The efficiency of PEI-based transfection was >60% (even in
co-transfected cells). Primary cultures of striatal neurons were
obtained from fetal CD-1 mice (embryonic day 16; E16) (Penrod
et al., 2011). In brief, after removing brain meninges, striatal
tissue was dissected and digested in 0.25% trypsin for 15min.
Trypsinization process was stopped by aspirating the media and
washing three times with filtrated HBSS solution. After passage
through a 100 µm-pore mesh and pelleting (3min at 300 x g),
neurons were resuspended in DMEM medium and seeded in
poly-D-lysine coated 6-well plates at 500.000 cells/well or 100.000
cells/18mm coverslip. 24 h later, the medium was replaced and
cells were maintained in Neurobasal medium (Gibco; Paisley,
Scotland, UK) supplemented with 5% FBS, 2mM L-glutamine,
100 U/ml P/S and 2% (v/v) B27 supplement. The cells were
maintained at 37◦C in humidified 5% CO2 atmosphere for 12
days before utilization, being the medium replaced once a week.
Bioluminescence Resonance Energy
Transfer (BRET) Assays
HEK-293T cells were transiently cotransfected with a constant
amount of cDNA encoding for either CB1-RLuc, calneuron-
1-RLuc or NCS1-RLuc and increasing amounts of cDNAs for
caldendrin-YFP, NCS1-YFP, calneuron-1-YFP, NCS11myristoil-
YFP, calneuron-11CT-YFP, CB1C1 -YFP or CB
IL3
1 -YFP. 48 h after
transfection cells were adjusted to 20 µg of protein using a
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Bradford assay kit (Bio-Rad, Munich, Germany) and using
bovine serum albumin for standardization. To quantify protein-
YFP expression, fluorescence was read in a Mithras LB
940 (Berthold Technologies, DLReady, Germany). For BRET
measurements, readings were collected 1min after the addition
of 5µM coelenterazine H (P.J.K. GmbH; Kleinblittersdorf,
Germany) using a Mithras LB 940, which allows the integration
of the signals detected in the short-wavelength filter at 485 nm
and the long-wavelength filter at 530 nm. To quantify protein-
RLuc expression, luminescence readings were performed 10min
after coelenterazine H addition. The net BRET is defined as
[(long-wavelength emission)/(short-wavelength emission)]-Cf,
where Cf corresponds to [(long-wavelength emission)/(short-
wavelength emission)] for the donor construct expressed alone
in the same experiment. GraphPad Prism software (San Diego,
CA, USA) was used to fit data. BRET is expressed as milli BRET
units, mBU (net BRET× 1,000).
Western Blotting
The determination of protein expression levels by
immunoblotting was carried out in transiently transfected
HEK-293T cells. 48 h after transfection, cells were collected,
centrifuged and resuspended in ice-cold Tris-HCl buffer pH 7.4
containing protease inhibitor (1/1,000). Then, cell suspension
was disrupted with a Polytron homogenizer (PTA 20 TS rotor,
setting 3; Kinematica, Basel, Switzerland) for three 5-s periods,
and membranes were obtained by centrifugation at 16,000 g
(30min, 4◦C). Pellet was resuspended in PBS-NP-40 1% buffer
for 1h. After centrifugation at 16,000 g (30min, 4◦C), protein was
quantified by the bicinchoninic acid method (Pierce Chemical
Co., Rockford, IL, USA) using BSA dilutions as standard.
Equivalent amounts of protein (20 µg) were separated by
polyacrylamide gel electrophoresis on denaturating conditions
(10% SDS). Proteins in gels were transferred into PVDF
membranes, which were then treated with blocking solution
and PBS (1:1 v/v) for 1 h. Primary antibodies against NCS1
(rabbit anti NCS1, 1/1,200; AbCam) or against calneuron-1
(rabbit anti calneuron-1, 1/2,000; AbCam) diluted in PBS buffer
were added and kept over-night at 4◦C. After removal of the
primary antibody and several washes with PBS-Tween 20 0.05%,
membranes were incubated for 1 h with a goat-anti-rabbit
IRDye 680RD secondary antibody (LI-COR Bioscience, Lincoln,
USA; dilution 1:10,000). Several washes were performed before
quantification using an Odyssey infrared scanner (LI-COR
Bioscience, Lincoln, USA) and the Odyssey software.
Immunocytochemistry
Transfected HEK-293T cells were fixed in 4% paraformaldehyde
for 15min and washed three times with PBS containing 20mM
glycine before permeabilization with PBS-glycine containing
0.2% Triton X-100 (10min incubation). Cells were treated
for 1 h with PBS containing 1% bovine serum albumin
and labeled overnight with the mouse anti-RLuc primary
antibody (1/50; Millipore), and subsequently treated with a
Cy3-conjugated anti-mouse secondary antibody [1/200; Jackson
ImmunoResearch (red)] IgG (1 h each). Samples were washed
several times and mounted with 30% Mowiol (Calbiochem).
Samples were observed in a Leica SP2 confocal microscope (Leica
Microsystems). YFP-fused protein were detected by the yellow
fluorescence. Nuclei were stained with Hoechst (SigmaAldrich,
1/100). Scale bar: 20µm.
cAMP Determination
Two hours before initiating the experiment, neuron culture
medium was replaced by serum-starved DMEM medium.
Then, cells were detached and resuspended in serum-starved
DMEM medium containing 50µM zardaverine, 0.1% BSA
and 5mM HEPES. Cells were plated in 384-well microplates
(2,000 cells/well), pretreated (15min) with the corresponding
antagonists -or vehicle- and stimulated with agonists (15min)
before adding 0.5µM forskolin (15min). Readings were
performed after 1 h incubation at 25◦C. Homogeneous time-
resolved fluorescence energy transfer (HTRF) measures were
performed using the Lance Ultra cAMP kit (PerkinElmer,
Waltham, MA, USA). According to the manufacturer and to
our previous experience phenol red in DMEM does not affect
cAMP concentration determinations. Fluorescence at 665 nm
was analyzed on a PHERAstar Flagship microplate reader
equipped with an HTRF optical module (BMG Lab technologies,
Offenburg, Germany).
In Situ Proximity Ligation Assay (PLA)
Neurons grown on glass coverslips were fixed in 4%
paraformaldehyde for 15min, washed twice with PBS containing
20mM glycine to quench the aldehyde groups and permeabilized
with the same buffer containing 0.05% Triton X-100 (10min
treatment). After 1 h incubation at 37◦ with blocking solution,
cells were treated with specific antibodies against CB1 (rabbit anti
CB1R, 1/100; Invitrogen), calneuron-1 (rabbit anti calneuron-1,
1/100; AbCam) and NCS1 (rabbit anti NCS1, 1/100; AbCam)
conjugated with Duolink In Situ Probemaker oligonucleotides
(CB1R was labeled with Duolink In Situ Probemaker Minus
and anti-NCS1 and anti-calneuron-1 antibodies were labeled
with Duolink In Situ Probemaker Plus). Nuclei were stained
with Hoechst (1/200; SigmaAldrich) and samples were mounted
with 30% Mowiol (Calbiochem) and observed in a Leica
SP2 confocal microscope (Leica Microsystems, Mannheim,
Germany) equipped with an apochromatic 63X oil-immersion
objective using 405 nm and 594 nm laser lines.
For each field of view a stack of two channels (one per staining)
and four stacks with a step size of 0.5µm were acquired. The
number of cells containing one or more red spots vs. total cells
(blue nucleus) and, in cells containing spots, the ratio r (number
of red spots/cell), were determined by means of the Duolink
Image tool software.
RESULTS
EF-Hand CaM-Like Sensors Interact With
the CB1R
To determine whether CB1R can form heteromeric complexes
with calcium-binding proteins, an immunocytochemistry assay
was first developed to assess whether CB1R and three calcium
sensors of relevance in neurons, may co-localize in co-transfected
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cells. HEK-293T cells were transfected with cDNAs for CB1-
RLuc, and either calneuron-1-YFP, NCS1-YFP or caldendrin-
YFP. Calcium-binding protein expression was detected by
fluorescence while CB1R fused to RLuc was detected by the
use of an anti-RLuc antibody and a Cy3-conjugated secondary
antibody. Figure 1A shows expression of proteins in cells
transfected with cDNAs encoding for CB1-RLuc and a calcium-
sensor fused to YFP. Cell expression was similar to that
observed when cells were transfected with only one fusion
protein (Supplementary Figure 1). The degree of overlapping
of immunoreactivity was moderate for CB1 and each of the
calcium sensors tested (Figure 1A). To demonstrate a potential
physical interaction between receptor pairs, a bioluminescence
resonance energy transfer (BRET) approach was used. BRET
was undertaken in HEK-293T cells expressing a constant
amount of cDNA for CB1-RLuc and increasing amounts of
cDNAs for calneuron-1-YFP, NCS1-YFP or caldendrin-YFP. For
calneuron-1-YFP and NCS1-YFP a saturation BRET curve was
obtained, thus indicating a specific interaction between CB1-
RLuc and those two calcium binding proteins. BRET parameter
values were: BRETmax 30 ± 3 mBU and BRET50 10± 3 for
the interaction with calneuron-1, and BRETmax 170 ± 20
mBU and BRET50 70 ± 10 for the interaction with NCS1
(Figures 1B,C). Interestingly, the increase of intracellular Ca2+
concentration by pre-incubation for 30min with ionomycin, a
ionophore that increases intracellular calcium ion levels, did not
modify the degree of interaction (Figures 1B,C). In contrast,
an unspecific linear signal was obtained between CB1 and
caldendrin-YFP, indicating the lack of interaction between these
proteins (Figure 1D). Actually, these results constitute a proper
negative control of the assay. In summary, the results indicate
that at basal or increased Ca2+ intracellular levels, CB1R may
interact with calneuron-1 or NCS1 but not with caldendrin.
Mapping the Interaction Motives
Taking into account data on motives in the structure of calcium
sensors and the general organization of heptaspanning GPCRs,
BRET assays were undertaken using different mutated versions
of CB1R and calneuron-1 or NCS1. As indicated in Material
and Methods, plasmids containing the sequences of either the
third intracellular loop or the C-terminal deletion mutants of
CB1R were used (see details in section Methods). For calcium
sensors, NCS1 was mutated deleting the myristoylation site
in the N-terminal domain of NCS1, and a part of the C-
terminal end of calneuron-1 was deleted to prevent membrane
insertion. Images showing expression of mutated proteins are
displayed in Supplementary Figure 2. BRET assays using RLuc
or YFP fusion proteins containing the mutated proteins led
to the results displayed in Figure 2. On the one hand, the
BRET results show that mutant versions of calneuron-1 and
NCS1 cannot interact with the CB1R. On the other hand, the
mutated form in the third intracellular loop of the CB1R receptor
abolished the interaction with both calcium sensor proteins.
Finally, deletion of the C-terminal domain led to unspecific signal
when NCS1-YFP was used but did not significantly alter the
direct interaction established between calneuron-1-YFP and the
cannabinoid receptor. These results suggest that NCS1 directly
interact with the C-terminal tail and the third intracellular loop of
the CB1R, while calneuron-1 only interacts with the C-terminal
domain of the receptor.
Calneuron-1 and NCS1 Compete for the
Interaction With CB1R
The above described results concerning G-protein-mediated
signaling suggested that the two calcium-binding proteins
might compete for binding to the cannabinoid receptor. To
confirm this hypothesis, we performed BRET competition
assays by expressing CB1-RLuc and one sensor fused to
YFP in the presence of increasing amounts of the second
calcium sensor. BRET assays were performed in cells treated
or not with ionomycin and the results are presented in
Figure 3. Results using increasing amounts of cDNA for NCS1
indicate that the protein was able to dose-dependently compete
for the binding of calneuron-1 to CB1R; such competence
disappeared in the presence of increased intracellular Ca2+
concentrations (Figure 3A). Just the opposite was found when
using increasing amounts of cDNA for calneuron-1, which did
compete for the binding of NCS1 to the receptor when the
concentrations of intracellular Ca2+ were elevated (Figure 3B).
The results indicate that in basal conditions CB1R is more
likely interacting with NCS1, while relatively high cytoplasmic
calcium ion concentrations favor the binding of calneuron-1 to
the receptor.
Occurrence of Receptor-Calcium Sensor
Complexes in Striatal Neurons
Mouse striatum was chosen to prepare neuronal primary
cultures and look for interactions between the CB1R and
calneuron-1 or NCS1. In order to detect receptor-sensor
complexes in primary cultures of neurons, PLA assays were
carried out in cells treated or not with ionomycin. Red
dots/clusters indicating the occurrence of receptor-calneuron-
1 and receptor-NCS1 complexes were found in all conditions
(Figure 4A). The absence of the primary anti-CB1R or anti-
sensor antibodies led to a marked reduction of the PLA
signal (Figure 4B, Supplementary Figure 3). The number of
cells containing one or more red spots vs. total cells (blue
nucleus) and, in cells containing spots, the ratio r (number
of red spots/cell), were determined by means of the Duolink
Image tool software. Significant differences were found in both
basal conditions and after treatment with ionomycin. In basal
conditions, the number of cells expressing CB1R-calneuron-
1 complexes and the relative number of clusters was lower
than in the case of the CB1R-NCS1 pair. The results were
totally opposite when neurons were treated with ionomycin,
which led to a marked reduction in the percentage of cells
expressing CB1R/NCS1 complexes (and in the spot/cell ratio)
and a marked increase in the percentage of cells expressing
CB1R/calneuron-1 complexes (and in the spot/cell ratio)
(Figure 4B). Collectively, the results indicate that low calcium
concentrations favor the interaction with NCS1, whereas CB1R
is mainly bound to calneuron-1 when intracellular Ca2+ levels
increase (Figure 4B). It should be noted that the effect of ACEA,
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FIGURE 1 | Interaction of CB1R with calcium sensor proteins. For immunocytochemistry assays HEK-293T cells were co-transfected with cDNAs for CB1-RLuc (1.5
µg) and calneuron-1-YFP (2 µg), CB1-RLuc (1.5 µg) and NCS1-YFP (2 µg) or CB1-RLuc (1.5 µg) and caldendrin-YFP (3 µg). Cells were processed as described in
section Materials and Methods. (A) CB1-RLuc was detected using a specific anti-RLuc antibody and a Cy3-conjugated secondary antibody, whereas sensor-YFP
fusion proteins were detected by the yellow fluorescence due to YFP; merge is shown in images in the right, in which colocalization appears in yellow. Lower
magnification (left) and high magnification images (right) are shown. (B–D) BRET assays were performed in HEK-293T cells transfected with cDNA for CB1-RLuc (1.5
µg) and increasing amounts of cDNAs for calneuron-1-YFP (0.25–2 µg) (B), NCS1-YFP (0.5–2.5 µg) (C) or caldendrin-YFP (1–3 µg) (D), in the presence (red) or
absence (black) of 1µM ionomycin. Values are the mean ± S.E.M. of 10 different experiments in duplicates.
the CB1R agonist, was markedly affected by preincubation of
neurons with ionomycin (Figure 4C). Of note, the combination
of calcium mobilization and receptor activation results in
higher cAMP levels being the net effect equivalent to a Gs
coupling and not to a Gi coupling as it occurred in basal
conditions.
DISCUSSION
GPCR receptor action may be modulated in different ways
depending on the cellular context. GPCR-mediated signaling not
only depends on the coupled G protein but on other molecules
able to interact with the receptor and/or with the signaling
machinery. The potential relationships between calcium-binding
proteins and GPCRs are poorly understood despite pioneering
articles showing that calmodulin is involved in hormone action
(Means and Dedman, 1980), regulates GPCR kinases (Iacovelli
et al., 1999) and impacts on the activity of enzymes that
regulate cAMP levels after activation of dopamine and opioid
receptors (Hanbauer et al., 1979). Calmodulin was likely the
first calcium-binding protein that was identified as a modulator
of GPCRs relevant for neurotransmission (Woods et al., 2008;
Navarro et al., 2009; Ferré et al., 2010; Fuxe et al., 2010; Chen
et al., 2011; Magalhaes et al., 2012). However, the knowledge
about the impact in GPCR biology of other neuronal calcium
sensors is still preliminary (Mikhaylova et al., 2011). In this
study, we aimed at looking for interactions between the most
abundant GPCR in the CNS, CB1R and three abundantly
expressed calcium sensors (NCS1, calneuron-1 and caldendrin)
with known function. Caldendrin is highly enriched at synaptic
sites (Seidenbecher et al., 1998) and binds various synaptic
proteins (Seidenbecher et al., 2004; Dieterich et al., 2008; Gorny
et al., 2012; Mikhaylova et al., 2018). The results showed
interaction of the GPCR with calneuron-1 and NCS1 but not
with caldendrin, and competence of calneuron-1 and NCS1 for
the binding to the receptor that was calcium-dependent. To our
knowledge no interaction between caldendrin and any GPCR has
been reported.
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FIGURE 2 | Determination of interacting domains for CB1R-calneuron-1 and CB1R-NCS1 complexes. BRET assays were performed in HEK-293T cells transfected
with cDNA for CB1-RLuc (1.5 µg) and increasing amounts of cDNA for calneuron-1
1CTYFP (1–3 µg) (A), cDNA for calneuron-1RLuc (3 µg) and increasing amounts
of cDNA for CB1R
1CTYFP (0.25–1.5 µg) (B), cDNA for calneuron-1-RLuc (3 µg) and increasing amounts of cDNA for CB1R
IL3YFP (0.5–2 µg) (C), cDNA for
CB1-RLuc (1.5 µg) and increasing amounts of cDNA for NCS1
1myristoilYFP (1–3 µg) (D); cDNA for NCS1-RLuc (2.5 µg) and increasing amounts of cDNA for
CB1R
1CTYFP (0.25–1.5 µg) (E) and cDNA for NCS1-RLuc (2.5 µg) and increasing amounts of cDNA for CB1R
IL3YFP (0.5–2 µg) (F). Values are the mean ± S.E.M.
of 8 different experiments in duplicates.
FIGURE 3 | Calneuron-1 and NCS1 compete for interacting with CB1R. BRET assays were performed in HEK-293T cells transfected with cDNAs for CB1R (1.25 µg)
and calneuron-1-YFP (2 µg) and increasing amounts of cDNAs for NCS1 (0–1 µg) (A), for CB1R (1.25 µg) and NCS1-YFP (1.5 µg) and increasing amounts of cDNA
for calneuron-1 (0–1 µg) (B), in the presence (blue) or absence (black) of 1µM ionomycin. Bottom images show the results of a representative Western blotting in
which NCS1 or calneuron-1 were detected. Values are the mean ± S.E.M. of 10 different experiments in duplicates and a one-way ANOVA followed by a Dunnett’s
post-hoc test was used for statistical comparison (*p < 0.05; **p < 0.01 comparing absence vs. presence of ionomycin).
It has been previously described that NCS1 can interact with
dopamine D2 (Woll et al., 2011) and adenosine A2A (Navarro
et al., 2012) receptors. In turn, calneuron-1 can also establish
interactions with the A2A − D2 receptor heteromer (Navarro
et al., 2014). The cannabinoid CB1R is involved in different
interaction whose interface motives are partially characterized.
Intracellular loops (particularly the 2nd and the 3rd) are involved
in coupling to heterotrimeric G proteins and also to other
scaffolding and/or signaling proteins (Khan and Lee, 2014). Also,
the C-terminal domain of GPCRs arise as important for directing
signaling to different pathways thus contributing to functional
selectivity (Stadel et al., 2011; Navarro et al., 2018). It has been
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FIGURE 4 | Identification of interactions between calcium sensor proteins and CB1R in primary cultures of mouse striatal neurons. (A,B) In situ PLA detection of
CB1R-calneuron-1 and CB1R-NCS1 complexes was performed as described in Material and Methods using primary cultures assayed in the presence or absence of
1µM ionomycin. Interactions were detected as red spots in Hoechst-stained nuclei in the confocal microscopy images shown (superimposed sections of 0.5µm total
thickness). Scale bar: 20µm (A). Dots (number of red spots) per cell and percentage of cells containing red spots are shown in the bar graphs. Data are the mean ±
S.E.M of counts of 8 different fields for every condition. A one-way ANOVA followed by a Tukey’s multiple comparison test was performed for the statistical analysis
(*p < 0.05; **p < 0.01) (B). (C) Effect of 100 nM ACEA on 0.5µM forskolin-induced intracellular cAMP levels determined in striatal neurons pretreated or not with
1µM rimonabant. Basal and forskolin-induced concentrations were, respectively 0.3 ± 0.2 and 3.7 ± 0.5 nM. Experiments were carried out in the absence (black)
and presence (blue) of a calcium ionophore (1µM ionomycin). Data are given as percentage of cAMP concentration induced by forskolin; data are the mean ± S.E.M.
of 6 different experiments in triplicates. A one-way ANOVA followed by a Dunnett’s post-hoc test was used for statistical comparison (*p < 0.05 comparing absence
vs. presence of ionomycin).
also suggested that structural features in the 2nd intracellular
loop may be responsible for a change of coupling from the
cognate Gi to a Gs protein (Chen et al., 2010) and that the third
intracellular loop is important for constitutive activation (Abadji
et al., 2008). Based on preliminary assays and on previous data
we tested CB1 receptors that were mutated in amino acids that
are responsible for electrostatic interaction with other proteins
(Navarro et al., 2010). Plasmids were prepared containing the
CB1R in which two conserved residues that are susceptible of
phosphorylation (thus acquiring negative charges) were mutated
to Ala. Similar mutations were done in peptide strings in both
the third intracellular loop (CB1R
IL3) and the C-terminal end
(CB1R
1C). One of the remarkable findings was the asymmetric
interaction mode with calcium sensors; whereas mutations in the
third intracellular loop abolished binding to the two calcium-
binding proteins, mutations in the C-terminal domain abolished
interaction with NCS1 but not with calneuron-1. In summary, we
were able to achieve one of our interests, which was to look for
structural differences in the interaction between the CB1R and
calneuron-1 or NCS1.
We here demonstrate that CB1R function might be regulated
by direct interactions with calcium sensors that in turn depend
on the level of intracellular Ca2+. It is also demonstrated that
the Gi- coupled CB1R is functionally affected by the calcium
concentration and by the interaction with calcium sensors in
such a way that the output may be similar to that of Gs-coupled
receptors. Calcium sensors may also modulate Gs-coupled
GPCRs. For instance, in the case of Gs-coupled adenosine A2A
receptors, NCS1 is the protein that modulates receptor signaling
in a calcium concentration-dependent fashion (Navarro et al.,
2012). Taken together, the evidence points to Ca2+ levels as
relevant to regulate the function of receptors whose signaling is
dependent on cAMP as second messenger.
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Supplementary Figure 1 | Expression of CB1R and calcium sensor fusion
proteins. HEK-293T cells were transfected with cDNAs for CB1-RLuc (1 µg)
(A,E,F), calneuron-1-YFP (1.5 µg) (B), NCS1-YFP (1.5 µg) (C) or caldendrin-YFP
(1.75 µg) (D). Immunocytochemical assays were performed as described in
section Materials and Methods. In order to ensure the specificity of the antibodies
employed, negative controls were developed by omitting the primary anti-RLuc
antibody (E) or the Cy3-conjugated secondary antibody (F). Scale bar: 30µm.
Supplementary Figure 2 | Expression of calcium sensor fusion protein mutants.
HEK-293T cells were transfected with plasmids containing, for CB1R, the
sequence containing mutations forms in the third intracellular loop and the
sequence lacking the C-terminal domain; for NCS1, the sequence lacking the
myristoylation site in the N-terminal domain of NCS1 and, for calneuron-1, the
sequence lacking of the C-terminal domain involved in membrane insertion.
Detection was performed by fluorescence using a confocal microscope. Scale
bars: 10µm.
Supplementary Figure 3 | Negative controls in PLA Assays. Negative controls
for in situ PLA assays were performed in primary cultures of mice striatal neurons
by omitting either the anti-CB1R (A), the anti-NCS1 (B) or the anti-calneuron-1
(C) antibodies. Scale bar: 30µm.
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